The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian Cohort of Obese Women
Table 3
Obese patients with or without metabolic syndrome, subdivided among age ranges, having altered IDF criteria.
Evidence
IDF criteria (cut-off)
18–30 (n = 98)
31–40 (n = 106)
41–50 (n = 196)
51–60 (n = 292)
61–70 (n = 239)
>70 (n = 69)
β1
Y-Intercept
p
WC (≥80 cm)
MetS+
25 (100%)
54 (100%)
117 (100%)
203 (100%)
182 (100%)
49 (100%)
—
—
—
MetS−
73 (100%)
52 (100%)
79 (100%)
89 (100%)
57 (100%)
20 (100%)
—
—
—
HDL-C (<50 mg/dl)
MetS+
24 (96%)a
50 (92.6%)a
104 (88.9%)a
146 (71, 9%)a
138 (75.8%)a
35 (71.4%)a
−0.0061
1.12
<0.001
MetS−
39 (53.4%)
20 (38.5%)
18 (22.8%)
6 (6.7%)
4 (7.0%)
0 (0.0%)
−0.0121
0.80
<0.001
Triglycerides (≥150 mg/dl)
MetS+
13 (52%)a
33 (61.1%)a
59 (50.4%)a
117 (57.6%)a
93 (51.1%)a
26 (53.1%)a
−0.0005
0.57
0.745
MetS−
2 (2.7%)
1 (1.9%)
4 (5.1%)
2 (2.2%)
1 (1.7%)
0 (0.0%)
−0.0003
0.04
0.559
Glucose (≥100 mg/dl)
MetS+
7 (28%)a
16 (29.6%)a
47 (40.2%)a
119 (58.6%)a
114 (62.6%)a
31 (63.3%)a
0.0104
−0.11
<0.001
MetS−
0 (0.0%)
0 (0.0%)
2 (2.5%)
3 (3.4%)
2 (3.5%)
0 (0.0%)
0.0006
−0.013
0.138
BP (SBP ≥130 and/or DBP≥85 mmHg)
MetS+
18 (72%)a
37 (68.5%)a
97 (82.9%)a
192 (94.6%)a
176 (96.7%)a
47 (95.9%)
0.0069
0.52
<0.001
MetS−
6 (8.2%)
14 (26.9%)
34 (43.0%)
58 (65.2%)
36 (63.1%)
18 (90.0%)
0.0154
−0.28
<0.001
Abbreviations: DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; MetS-, negative for metabolic syndrome; MetS+, positive for metabolic syndrome; SBP, systolic blood pressure; WC, waist circumference. a: versus the corresponding MetS- subgroup (Fisher's exact test). Values of β1, Y-intercept and refer to the linear regression performed by using all data within each subgroup (MetS + or MetS-).
